15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $419M | $49M | 82.6% | 15.3% | — | $18M | $166M |
| 2024 | $349M | $42M | 82.8% | 16.9% | — | $19M | $104M |
| 2023 | $321M | $58M | 83.0% | 11.5% | $25M | $50M | $82M |
| 2022 | $268M | -$30M | 82.0% | -5.5% | -$19M | $50M | $66M |
| 2021 | $242M | -$10M | 83.6% | -2.9% | -$5M | $50M | $87M |
| 2020 | $248M | -$49M | 84.2% | -18.3% | — | $50M | $96M |
| 2019 | $299M | -$26M | 85.6% | -7.1% | — | $73M | $69M |
| 2018 | $359M | -$30M | 89.9% | -1.1% | — | $0 | $45M |
| 2017 | $321M | $65M | 89.0% | 14.4% | — | — | $27M |
| 2016 | $222M | $390000 | 86.0% | 0.4% | — | — | $30M |
| 2015 | — | $29M | — | — | — | — | $26M |
| 2014 | — | $6M | — | — | — | — | $47M |
| 2013 | — | -$4M | — | — | — | $0 | $44M |
| 2012 | — | -$8M | — | — | — | $4M | $7M |
| 2011 | — | -$10M | — | — | — | $4M | $4M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $59M | -$11M | 70.6% | -27.2% | — | $18M | $160M |
| Dec '25 | $118M | $15M | 83.9% | 17.8% | — | $18M | $166M |
| Sep '25 | $114M | $17M | 83.5% | 19.5% | — | $18M | $142M |
| Jun '25 | $99M | $10M | 81.1% | 12.5% | — | $18M | $119M |
| Mar '25 | $88M | $7M | 81.2% | 9.4% | — | $19M | $106M |
| Dec '24 | $93M | $7M | 81.8% | 11.9% | — | $19M | $104M |
| Sep '24 | $84M | $8M | 81.8% | 13.3% | — | $19M | $89M |
| Jun '24 | $87M | $18M | 83.0% | 26.9% | — | $19M | $69M |
| Mar '24 | $85M | $9M | 84.7% | 15.6% | — | $19M | $48M |
| Dec '23 | $87M | $53M | 84.1% | 17.8% | $10M | $50M | $82M |
| Sep '23 | $82M | $9M | 81.9% | 13.6% | $12M | $49M | — |
| Jun '23 | $81M | $1M | 83.3% | 13.3% | $7M | $49M | $69M |
| Mar '23 | $72M | -$5M | 82.7% | -0.5% | -$5M | $49M | $61M |
| Dec '22 | $74M | -$414000 | 80.7% | 15.2% | -$6M | $50M | $66M |
| Sep '22 | $68M | -$8M | 82.0% | -10.5% | $610000 | $48M | $73M |
| Jun '22 | $67M | -$11M | 82.3% | -14.4% | -$3M | $48M | $73M |
| Mar '22 | $59M | -$10M | 83.1% | -15.8% | -$10M | $48M | $76M |
| Dec '21 | $67M | $2M | 84.0% | 4.9% | — | $50M | $87M |
| Sep '21 | $63M | -$2M | 83.9% | -1.7% | $6M | $50M | $91M |
| Jun '21 | $68M | -$2M | 81.3% | -0.6% | $1M | $50M | $85M |
How the market has priced MDXG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Mimedx Group, Inc.'s revenue has grown 11.0% per year. These are computed facts, not advice.
As of FY2025, Mimedx Group, Inc. reported $18M of total debt against $166M of cash; operating income covered interest expense 36×.
In FY2025, gross margin was 82.6%, operating margin 15.3%, and net margin 11.6%.
As of Jun '26, Mimedx Group, Inc. traded at a price-to-earnings ratio of about 11.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.